Preclinical PET/MR
Positron emission tomography (PET) is a sensitive and quantitative in vivo molecular imaging technique used to trace the fate of biologically relevant radiolabeled molecules in living beings. When combined with magnetic resonance imaging (MRI), PET/MRI provides improved anatomical information and opportunities for in vivo measurement of physiological parameters, such as flow, perfusion and diffusion.
The preclinical PET/MRI system should have the capacity to perform approximately 500 small animal imaging examinations/year. The system will be installed at the Preclinical PET Platform (PPP) at Uppsala University.
Sista ansökningsdag
Tidsfristen för mottagande av anbud var 2015-02-10.
Upphandlingen offentliggjordes den 2014-12-19.
Leverantörer
Följande leverantörer nämns i tilldelningsbeslut eller andra upphandlingsdokument:
Vem?
Vad?
Var?
Upphandlingshistorik
| Datum |
Dokument |
| 2014-12-19
|
Meddelande om upphandling
|
| 2015-01-27
|
Ytterligare upplysningar
|
| 2015-10-14
|
Meddelande om tilldelning
|